MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Prepaid expenses andother current assets$6,421K Inventories$7,782K Accounts receivable, net$36,451K Short-term investments$228,652K Cash and cashequivalents$59,557K Other assets$2,918K Intangible assets, net$14,729K Fixed assets, net$1,209K Right-of-use asset$1,439K Long-term inventories$13,645K Total current assets$338,863K Total assets$372,803K Total liabilities andstockholders' equity$372,803K Total stockholders'equity$147,655K Total liabilities$225,148K Accumulated deficit-$253,279K Accumulated othercomprehensive (loss) gain, net-$7K Additionalpaid-incapital$400,931K Other accruedliabilities$3,781K Lease liability, netof current portion$949K Contract liability, netof current portion$1,268K Financing liability$72,044K Term loans, net(including related party...$96,229K Total currentliabilities$50,877K Common stock, 0.0001par value per share...$10K Lease liability,current$583K Contract liability,current$526K Accounts payable andaccrued liabilities...$49,768K
Balance Sheet
source: myfinsight.com

ARS Pharmaceuticals, Inc. (SPRY)

ARS Pharmaceuticals, Inc. (SPRY)